VWR International will supply Kapa Biosystems’ line of next-generation PCR reagents in North America. Kapa Biosystems employs a high-throughput molecular evolution technology platform to engineer DNA-modifying enzymes for applications in DNA amplification, next-generation sequencing, and molecular diagnostics. Kapa says that the DNA polymerases contained in its reagents possess amino acid modifications that help improve the function of the enzymes.

Previous articleThe Big Week for Investor Visibility, JP Morgan
Next articleGVK Biosciences Joins ResearchPoint Global’s Worldwide CRO Network